Roberto Michelucci

Dr. Roberto Michelucci


Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2014 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MMMikko Muona
Mikko Muona
Sam BerkovicSam Berkovic
Sam Berkovic
LDLeanne M Dibbens
Leanne M Dibbens
KOKaren L Oliver
Karen L Oliver
SMSnezana Maljevic
Snezana Maljevic
ALAnna-Elina Lehesjoki
Anna-Elina Lehesjoki

1 September 2000 in Clinical Neurophysiology
Verified
Journal Article
Closed access
CTC.A Tassinari
C.A Tassinari
GRG Rubboli
G Rubboli
LVL Volpi
L Volpi
SMStefano Meletti
Stefano Meletti
GDG D'ORsi
G D'ORsi
RMRoberto Michelucci
Roberto Michelucci

1 February 1999 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JSJosé M. Serratosa
José M. Serratosa
PGPilar Gomez-Garre
Pilar Gomez-Garre
M. ESTHER GALLARDO PEREZM. ESTHER GALLARDO PEREZ
M. ESTHER GALLARDO PEREZ
BABerta Anta
Berta Anta
DBDaniel Beltrán-Valero de Bernabé
Daniel Beltrán-Valero de Bernabé
SCSantiago Rodríguez De Córdoba
Santiago Rodríguez De Córdoba
Progressive myoclonus epilepsy of the Lafora type or Lafora disease (EPM2; McKusick no. 254780) is an autosomal recessive disorder characterized by epilepsy, myoclonus, progressive neurological deterioration and glycogen-like intracellular inclusion bodies (Lafora bodies). A gene for EPM2 previously has been mapped to chromosome 6q23–q25 using linkage analysis and homozygosity mapping. Here we report the positional cloning of the 6q EPM2 gene. A microeletion within the EPM2 critical region, present in homozygosis in an affected individual, was found to disrupt a novel gene encoding a putative protein tyrosine phosphatase (PTPase). The gene, denoted EPM2, presents alternative splicing in the 5′ and 3′ end regions. Mutational analysis revealed that EPM2 patients are homozygous for loss-of-function mutations in EPM2. These findings suggest that Lafora disease results from the mutational inactivation of a PTPase activity that may be important in the control of glycogen metabolism.

14 June 2002 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
RFR Flink
R Flink
BPB Pedersen
B Pedersen
AGA B Guekht
A B Guekht
KMK Malmgren
K Malmgren
RMRoberto Michelucci
Roberto Michelucci
CGCommission of European Affairs of the International League Against Epilepsy: Subcommission on European Guidelines
Commission of European Affairs of the International League Against Epilepsy: Subcommission on European Guidelines
The Commission of European Affairs of the International League Against Epilepsy published `Appropriate Standards for Epilepsy Care Across Europe' which contained recommendations for the use of electr...

3 August 1996 in Epilepsia
Verified
Journal Article
Closed access
PDF file
CTC. A. Tassinari
C. A. Tassinari
RMRoberto Michelucci
Roberto Michelucci
PCP. Chauvel
P. Chauvel
JCJ. Chodkiewicz
J. Chodkiewicz
SSS. Shorvon
S. Shorvon
RKR. Karim
R. Karim

18 March 2011 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
FPF. Pastorelli
F. Pastorelli
MSM. Di Silvestre
M. Di Silvestre
RPR. Plasmati
R. Plasmati
RMRoberto Michelucci
Roberto Michelucci
TGT. Greggi
T. Greggi
PPP. Parisini
P. Parisini